Somatostatin monoacetate

CAS : 54472-66-1

Ref. 3D-ECA47266

Informations sur le produit

• Nom: Somatostatin monoacetate

Description

Somatostatin is a peptide hormone that regulates the release of insulin, glucagon, and growth hormones. Somatostatin monomethanesulfonate (SMS) is a water-soluble drug that has been used to treat acromegaly, cancer, and diabetes mellitus. SMS is available as an oil solution that can be administered by intravenous injection or by infusion pump. The phosphate group in SMS provides protection against degradation by proteolytic enzymes. The half-life of SMS is about 5 hours and it is excreted through the kidneys. Somatostatin monoacetate (SMA) is a synthetic analogue of somatostatin with a shorter half-life than SMS. SMA has been used for diagnostic purposes in nuclear medicine imaging studies to measure cardiac output and renal function in patients with congestive heart failure. It has also been used for treatment of prostate cancer, breast cancer, and ovarian cancer. Polymer conjugates of som

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,697.9 g/mol
• Formule: C₇₈H₁₀₈N₁₈O₂₁S₂
• Degré de pureté: Min. 95%